Efficacy and Safety of Pulpal Anesthesia Strategies during Endodontic Treatment of Permanent Mandibular Molars with Symptomatic Irreversible Pulpitis: A Systematic Review and Network Meta-analysis

2019 ◽  
Vol 45 (12) ◽  
pp. 1435-1464.e10 ◽  
Author(s):  
Maryam Zanjir ◽  
Nima Laghapour Lighvan ◽  
Carilynne Yarascavitch ◽  
Joseph Beyene ◽  
Prakesh S. Shah ◽  
...  
2020 ◽  
Vol 46 (10) ◽  
pp. 1387-1402.e4 ◽  
Author(s):  
Maryam Zanjir ◽  
Adam Sgro ◽  
Nima Laghapour Lighvan ◽  
Carilynne Yarascavitch ◽  
Prakesh S. Shah ◽  
...  

2016 ◽  
Vol 21 (1) ◽  
pp. 43-52 ◽  
Author(s):  
Armin Shirvani ◽  
Sayna Shamszadeh ◽  
Mohammad Jafar Eghbal ◽  
Laleh Alim Marvasti ◽  
Saeed Asgary

2018 ◽  
Vol 12 (1) ◽  
pp. 340-346 ◽  
Author(s):  
Gowri Sivaramakrishnan ◽  
Kannan Sridharan

Background: Ketorolac has advantages over other analgesics as a pre-anaesthetic medication. Considering this in mind, the present meta-analysis aims to identify the effect of oral ketorolac premedication on the anaesthetic efficacy of Inferior Alveolar Nerve Block (IANB) in patients with irreversible pulpitis. Methods: Full-texts of eligible studies were obtained from electronic databases. The extracted data was analysed using non-Cochrane mode in RevMan 5.0 software. Relative risk [95% CI] was calculated for the success of IANB. Results: Four studies were included for the final review. The success rate of IANB on 221 patients with relative risk of 1.87 [1.36, 2.56] was statistically significant favouring ketorolac. The mean difference for VAS in 171 patients was not statistically significant {-13.55 [-33.91, 6.82]}. Conclusion: Oral ketorolac can be successfully administered as a premedication before conventional inferior alveolar nerve block for endodontic treatment for irreversible pulpitis.


Sign in / Sign up

Export Citation Format

Share Document